糖尿病前期及2型糖尿病中血糖代谢异常、视网膜神经退行性变与微量白蛋白尿的关联
这项横断面研究纳入68名参与者,分为糖耐量正常组(23人)、糖尿病前期组(25人)和无糖尿病视网膜病变的2型糖尿病组(20人),比较黄斑厚度与全身代谢指标。结果显示随着血糖代谢异常加重,全层黄斑厚度呈渐进性变薄(P=0.015),且尿白蛋白肌酐比与黄斑周围区上、下、颞、鼻侧全层变薄显著相关。作者认为血糖代谢异常在出现可见视网膜病变之前即与黄斑变薄相关,并伴随微量白蛋白尿出现。
要点
- 三组间随血糖代谢异常加重,全层黄斑厚度呈渐进性变薄(P=0.015)。
- 尿白蛋白肌酐比与黄斑周围区上、下、颞、鼻侧全层变薄显著相关。
- 黄斑变薄与腰围、体质指数、血压、血脂谱或胰岛素抵抗无关联。
核心结论
- 血糖代谢异常加重在出现可见视网膜病变之前即与黄斑变薄相关,并与微量白蛋白尿同时出现。
- 视网膜神经退行性改变可能有助于识别血糖代谢异常终末器官损伤风险最高的人群。
研究设计与样本
- 横断面研究,纳入68名参与者:糖耐量正常组23人、糖尿病前期组25人、无糖尿病视网膜病变的2型糖尿病组20人。
- 进行人体测量学评估及HbA1c、空腹血糖、胰岛素、c肽、血脂谱、肾功能和尿白蛋白肌酐比实验室检测。
- 采用谱域光学相干断层扫描测量黄斑中央及黄斑周围区厚度,并与全身参数比较。
主要发现
- 三组基线人口学特征相似。
- Cuzick趋势检验显示随着血糖代谢异常加重,三组间全层黄斑厚度呈渐进性变薄(P=0.015)。
- 经Bonferroni事后校正后,尿白蛋白肌酐比与黄斑周围区上侧(R=-0.435;P=0.0002)、下侧(R=-0.409;P=0.0005)、颞侧(R=-0.429;P=0.003)及鼻侧(R=-0.493;P<0.0001)全层变薄显著相关。
- 黄斑变薄与腰围、体质指数、血压、血脂谱或胰岛素抵抗之间无关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To explore the association between retinal neurodegeneration and metabolic parameters in progressive dysglycemia. METHOD: A cross-sectional study was performed on 68 participants: normal glucose tolerance (n = 23), prediabetes (n = 25), and Type 2 diabetes without diabetic retinopathy (n = 20). Anthropometric assessment and laboratory sampling for HbA1c, fasting glucose, insulin, c-peptide, lipid profile, renal function, and albumin-to-creatinine ratio were conducted. Central and pericentral macular thicknesses on spectral domain optical coherence tomography were compared with systemic parameters. RESULTS: Baseline demographic characteristics were similar across all groups. Cuzick's trend test revealed progressive full-thickness macular thinning with increasing dysglycemia across all three groups (P = 0.015). The urinary albumin-to-creatinine ratio was significantly correlated with full-thickness superior (R = -0.435; P = 0.0002), inferior (R = -0.409; P = 0.0005), temporal (R = -0.429; P = 0.003), and nasal (R = -0.493; P < 0.0001) pericentral macular thinning, after post hoc Bonferroni adjustment. There was no association between macular thinning and waist circumference, body mass index, blood pressure, lipid profile, or insulin resistance. CONCLUSION: Progressive dysglycemia is associated with macular thinning before the onset of visible retinopathy and occurs alongside microalbuminuria. Retinal neurodegenerative changes may help identify those most at risk from dysglycemic end-organ damage.
引用
- Kirthi V, Zuckerman BP, Alam U, et al. ASSOCIATIONS BETWEEN DYSGLYCEMIA, RETINAL NEURODEGENERATION, AND MICROALBUMINURIA IN PREDIABETES AND TYPE 2 DIABETES. Retina. 2022. PMID: 35188489. doi:10.1097/IAE.0000000000003337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。